Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) represent two distinct entities and recent studies have demonstrated that IL-18 and CXCL9 might serve as valuable biomarkers to distinguish both35. Here, CXCL9 is linked to macrophage activation syndrome.